Literature DB >> 26367487

miR-21 regulates tumor progression through the miR-21-PDCD4-Stat3 pathway in human salivary adenoid cystic carcinoma.

Lie-Hao Jiang1,2, Ming-Hua Ge2, Xiu-Xiu Hou1,2, Jun Cao1,2, Si-Si Hu1,2, Xiao-Xiao Lu1,2, Jing Han1, Yi-Chen Wu1, Xiang Liu1, Xin Zhu1, Lian-Lian Hong1, Pei Li3, Zhi-Qiang Ling1.   

Abstract

miR-21, which is a putative tumor onco-miR and frequently overexpressed microRNA in various tumors, has been linked to tumor progression through targeting of tumor-suppressor genes. In this study, we sought to determine whether miR-21 has any role on tumor progression of salivary adenoid cystic carcinoma (SACC) and the possible mechanisms. We found that the level of miR-21 expression was significantly higher in SACC than that in normal salivary tissues, and it is also higher in tumors with metastasis than that without metastasis. Using an anti-miR-21 inhibitor in an in vitro model, downregulation of miR-21 significantly decreased the capacity of invasion and migration of SACC cells, whereas a pre-miR-21 increased the capacity of invasion and migration of SACC cells. To explore the potential mechanisms by which miR-21 regulate invasion and migration, we identified one direct miR-21 target gene, programmed cell death 4 (PDCD4), which has been implicated in invasion and metastasis. The suppression of miR-21 in metastatic SACC-LM cells significantly increased the report activity of PDCD4 promoter and the expression of PDCD4 protein. This subsequently resulted in downregulation of the p-STAT3 protein. The level of miR-21 expression positively related to the expression of PDCD4 protein and negatively related to the expression of p-STAT3 protein in SACC specimens, respectively, indicating the potential role of the STAT3-miR-21-PDCD4 pathway in these tumors. Dysregulation of miR-21 has an important role in tumor growth and invasion by targeting PDCD4. Therefore, suppression of miR-21 may provide a potential approach for the treatment of advanced SACC patients.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26367487     DOI: 10.1038/labinvest.2015.105

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  48 in total

1.  Control of a tumor suppressor PDCD4: Degradation mechanisms of the protein in hepatocellular carcinoma cells.

Authors:  Sachiko Matsuhashi; Hiroshi Hamajima; Jinghe Xia; Hao Zhang; Toshihiko Mizuta; Keizo Anzai; Iwata Ozaki
Journal:  Cell Signal       Date:  2013-12-12       Impact factor: 4.315

2.  Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets.

Authors:  Benjamin P Lewis; Christopher B Burge; David P Bartel
Journal:  Cell       Date:  2005-01-14       Impact factor: 41.582

3.  Mapping of candidate tumor suppressor genes on chromosome 12 in adenoid cystic carcinoma.

Authors:  Sue Rutherford; Garret M Hampton; Henry F Frierson; Christopher A Moskaluk
Journal:  Lab Invest       Date:  2005-09       Impact factor: 5.662

4.  MicroRNA-21 targets tumor suppressor genes in invasion and metastasis.

Authors:  Shuomin Zhu; Hailong Wu; Fangting Wu; Daotai Nie; Shijie Sheng; Yin-Yuan Mo
Journal:  Cell Res       Date:  2008-03       Impact factor: 25.617

5.  STAT3 signaling is activated preferentially in tumor-initiating cells in claudin-low models of human breast cancer.

Authors:  Wei Wei; David J Tweardy; Mei Zhang; Xiaomei Zhang; John Landua; Ivana Petrovic; Wen Bu; Kevin Roarty; Susan G Hilsenbeck; Jeffrey M Rosen; Michael T Lewis
Journal:  Stem Cells       Date:  2014-10       Impact factor: 6.277

6.  Promoter methylation as a common mechanism for inactivating E-cadherin in human salivary gland adenoid cystic carcinoma.

Authors:  Chun-Ye Zhang; Li Mao; Lei Li; Zhen Tian; Xiao-Jian Zhou; Zhi-Yuan Zhang; Jiang Li
Journal:  Cancer       Date:  2007-07-01       Impact factor: 6.860

7.  MicroRNA profiling of salivary adenoid cystic carcinoma: association of miR-17-92 upregulation with poor outcome.

Authors:  Yoshitsugu Mitani; Dianna B Roberts; Hanadi Fatani; Randal S Weber; Merrill S Kies; Scott M Lippman; Adel K El-Naggar
Journal:  PLoS One       Date:  2013-06-25       Impact factor: 3.240

8.  Real-time quantification of microRNAs by stem-loop RT-PCR.

Authors:  Caifu Chen; Dana A Ridzon; Adam J Broomer; Zhaohui Zhou; Danny H Lee; Julie T Nguyen; Maura Barbisin; Nan Lan Xu; Vikram R Mahuvakar; Mark R Andersen; Kai Qin Lao; Kenneth J Livak; Karl J Guegler
Journal:  Nucleic Acids Res       Date:  2005-11-27       Impact factor: 16.971

9.  MiR-320a acts as a prognostic factor and Inhibits metastasis of salivary adenoid cystic carcinoma by targeting ITGB3.

Authors:  Lijuan Sun; Bodu Liu; Zhaoyu Lin; Yandan Yao; Yanyang Chen; Yang Li; Jianing Chen; Dongsheng Yu; Zhangui Tang; Bosheng Wang; Shuguang Zeng; Song Fan; Youyuan Wang; Yilin Li; Erwei Song; Jinsong Li
Journal:  Mol Cancer       Date:  2015-04-29       Impact factor: 27.401

10.  STAT3 in Cancer-Friend or Foe?

Authors:  Hai-Feng Zhang; Raymond Lai
Journal:  Cancers (Basel)       Date:  2014-07-03       Impact factor: 6.639

View more
  16 in total

1.  FZD6, targeted by miR-21, represses gastric cancer cell proliferation and migration via activating non-canonical wnt pathway.

Authors:  Jin Yan; Tingyu Liu; Xiaoying Zhou; Yini Dang; Chengqiang Yin; Guoxin Zhang
Journal:  Am J Transl Res       Date:  2016-05-15       Impact factor: 4.060

2.  Peroxisome proliferator-activated receptor-γ enhances human pulmonary artery smooth muscle cell apoptosis through microRNA-21 and programmed cell death 4.

Authors:  David E Green; Tamara C Murphy; Bum-Yong Kang; Brahmchetna Bedi; Zhihong Yuan; Ruxana T Sadikot; C Michael Hart
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-05-18       Impact factor: 5.464

3.  LRRC75A-AS1 targets miR-199b-5p/PDCD4 axis to repress multiple myeloma.

Authors:  Quantang Pang; Yanyan Wang; Dapeng Bi; Hongyu Lu
Journal:  Cancer Biol Ther       Date:  2020-11-01       Impact factor: 4.742

Review 4.  miR-21 Might be Involved in Breast Cancer Promotion and Invasion Rather than in Initial Events of Breast Cancer Development.

Authors:  Nina Petrović
Journal:  Mol Diagn Ther       Date:  2016-04       Impact factor: 4.074

Review 5.  The multifaceted role of STAT3 pathway and its implication as a potential therapeutic target in oral cancer.

Authors:  Elina Khatoon; Mangala Hegde; Aviral Kumar; Uzini Devi Daimary; Gautam Sethi; Anupam Bishyaee; Ajaikumar B Kunnumakkara
Journal:  Arch Pharm Res       Date:  2022-08-20       Impact factor: 6.010

6.  MiR21 sensitized B-lymphoma cells to ABT-199 via ICOS/ICOSL-mediated interaction of Treg cells with endothelial cells.

Authors:  Zhong Zheng; Peng-Peng Xu; Li Wang; Hui-Jin Zhao; Xiang-Qin Weng; Hui-Juan Zhong; Bin Qu; Jie Xiong; Yan Zhao; Xue-Feng Wang; Anne Janin; Wei-Li Zhao
Journal:  J Exp Clin Cancer Res       Date:  2017-06-21

7.  Role of miR-21 in the growth and metastasis of human salivary adenoid cystic carcinoma.

Authors:  Fei Yan; Chao Wang; Ting Li; Wenyan Cai; Jinhu Sun
Journal:  Mol Med Rep       Date:  2018-01-05       Impact factor: 2.952

Review 8.  MiR-21 in the Cancers of the Digestive System and Its Potential Role as a Diagnostic, Predictive, and Therapeutic Biomarker.

Authors:  Ha Thi Nguyen; Salah Eddine Oussama Kacimi; Truc Ly Nguyen; Kamrul Hassan Suman; Roselyn Lemus-Martin; Humaira Saleem; Duy Ngoc Do
Journal:  Biology (Basel)       Date:  2021-05-08

9.  Downregulation of Microrna-126 Contributes to Tumorigenesis of Squamous Tongue Cell Carcinoma via Targeting KRAS.

Authors:  Jingying Han; Lina Wang; Xiaofeng Wang; Kun Li
Journal:  Med Sci Monit       Date:  2016-02-17

10.  MiR-744-5p inducing cell death by directly targeting HNRNPC and NFIX in ovarian cancer cells.

Authors:  Michael Kleemann; Helga Schneider; Kristian Unger; Philip Sander; E Marion Schneider; Pamela Fischer-Posovszky; René Handrick; Kerstin Otte
Journal:  Sci Rep       Date:  2018-06-13       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.